Bectas Therapeutics
Business Services · Texas, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
3262 Westheimer Rd Ste 762, Houston, Tex...Website
www.bectastx.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Bectas Therapeutics
Bectas Therapeutics is a preclinical-stage biotech company focused on developing monoclonal antibody therapies for cancer, utilizing biomarkers to identify patients who will benefit most from their treatments. Their mission is to enhance immune-therapies for cancer, aiming to unlock the immune system's potential for curative therapies. The company combines best-in-class monoclonal antibodies with precision insights to create first-in-class therapies across various cancer indications. Their team possesses extensive expertise in precision oncology and the immune system's role in cancer, contributing to the development of effective therapies.Explore more
Popular SearchesBectas Therapeutics IncSIC Code 87,873NAICS Code 54,541Show moreBectas Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Bectas Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Bectas Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Bectas Therapeutics recently announced quarterly report
Bectas Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Click to see if Bectas Therapeutics had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Bectas Therapeutics has new funding data
Check out if Bectas Therapeutics is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Bectas Therapeutics
Product Launch: Get notified when Bectas Therapeutics launches new products
Recommended Actions
Reach out to Masked Content who joined Bectas Therapeutics as Masked Content
Find 3 more new buyers
Compare Similar Companies to Bectas Therapeutics
Compare insights from companies similar to Bectas Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Bectas Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Bectas Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Bectas Therapeutics.
Bectas Therapeutics Tech Stack
A closer look at the technologies used by Bectas Therapeutics
See more technologies
Bectas Therapeutics News & Media
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Bectas Therapeutics
Sign Up For FreeTo access detailed company insights
Bectas Therapeutics is a preclinical-stage biotech company focused on developing monoclonal antibody therapies for cancer, utilizing biomarkers to identify patients who will benefit most from their treatments. Their mission is to enhance immune-therapies for cancer, aiming to unlock the immune system's potential for curative therapies. The company... Read More
